Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
D000293:Adolescent; D000328:Adult; D000428:Alcohol Drinking; D001835:Body Weight; D002648:Child; D002791:Cholesterol, Dietary; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use; D004035:Diet Therapy; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004359:Drug Therapy, Combination; D005224:Fats, Unsaturated; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000235:genetics* / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D012855:Sitosterols / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D002791:Cholesterol, Dietary; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005224:Fats, Unsaturated; D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D002994:Clofibrate; D009355:Neomycin; D013974:Thyroxine